Hetero Labs Limited Pomalidomide Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Pomalidomide Export Records India — #3 Exporter, 7 Shipments, $32.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Pomalidomide

India Pharmaceutical Trade Intelligence

$4.4M108 Suppliers52 CountriesHS 30049099

ExportsIndia → COLOMBIA50.5%India → UNITED ARAB25.1%

ImportsUNITED STATES → India$1.8M BELGIUM → India$308.1K

#1 Supplier: MSN LABORATORIES #1 Buyer: MSN LABS

Hetero Labs Limited — Pomalidomide Exporter #3 | $32.3K Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Pomalidomide Exporter Profile

Indian Pharmaceutical Exporter · #3 for Pomalidomide · $32.3K export value · DGFT Verified

Hetero Labs Limited is the #3 Indian exporter of Pomalidomide with $32.3K in export value and 7 verified shipments. Hetero Labs Limited holds a 0.7% market share in Pomalidomide exports across 2 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Pomalidomide Export Profile: Buyers & Destinations

Hetero Labs Limited Pomalidomide export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Pomalidomide?

Country	Value	Shipments	Share
UNITED ARAB EMIRATES	$1.1M	48	42.3%
PERU	$658.9K	14	25.1%
COLOMBIA	$500.0K	10	19.1%
THAILAND	$69.2K	7

Who Are the Top Buyers of Pomalidomide from India?

Buyer	Country	Value	Orders
MSN LABS PERU SAC	PERU	$300.0K	6
MSN LABS AMERICAS SAS	COLOMBIA	$150.0K	3
AIMANT FZC	UNITED ARAB EMIRATES	$100.0K	2
MSN LABS AMERICAS SASNIT	COLOMBIA	$100.0K	2
WORLD HEALTH ORGANIZATION WAREHOUSE	UNITED ARAB EMIRATES	$100.0K	2
STR INTERNATIONAL TRADING CO., LTD	THAILAND	$66.6K	3
NATCO PHARMA (CANADA) INC	CANADA	$64.3K	4
ALQUIMIA LIMITED (COOKST PHARMACY)	NEW ZEALAND	$23.4K	20
DIDRSASR DISTRIBUIDORA DROGUERIA SAGITARIO SRL	PERU	$19.0K	2
TO THE	BRAZIL	$10.9K	13

India's Pomalidomide is purchased by 190 buyers worldwide. The top buyer is MSN LABS PERU SAC (PERU), followed by MSN LABS AMERICAS SAS and AIMANT FZC.

How Does Hetero Labs Limited Compare to Nearest Pomalidomide Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MSN LABORATORIES PRIVATE LIMITED	$950.0K	19	3	$50.0K
2	NATCO PHARMA LIMITED	$64.6K	5	2	$12.9K
3	HETERO LABS LIMITED ★	$32.3K	7	2	$4.6K
4	VISHAKHA IMPEX	$31.4K	25	1	$1.3K
5	3S PHARMACEUTICALS INDIA PRIVATE LIMITED	$26.8K	14	3	$1.9K

Hetero Labs Limited ranks #3 among 108 Indian Pomalidomide exporters. Average shipment value of $4.6K compared to the market average of $11.2K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and NATCO PHARMA LIMITED.

Which Indian Ports Ship Pomalidomide Exports?

Port	Shipments	% Share
SAHAR AIR	223	33.7%
SAHAR AIR CARGO ACC (INBOM4)	188	28.4%
Bombay Air	49	7.4%
Bombay Air Cargo	31	4.7%
DELHI AIR	30	4.5%
HYDERABAD AIR	21	3.2%
DELHI AIR CARGO ACC (INDEL4)	13	2.0%
HYDERABAD ACC (INHYD4)	13	2.0%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Pomalidomide Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pomalidomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 52+ countries, 190+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pomalidomide

Pomalidomide

Hetero Labs Limited — Pomalidomide Exporter Profile

Hetero Labs Limited — Pomalidomide Export Profile: Buyers & Destinations

Where Does India Export Pomalidomide?

Who Are the Top Buyers of Pomalidomide from India?

What Is India's Total Pomalidomide Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Pomalidomide Exports?

How Does Hetero Labs Limited Compare to Other Indian Pomalidomide Exporters?

Regulatory Requirements: Exporting Pomalidomide to Key Markets

Canada — HC

How Does Hetero Labs Limited Compare to Nearest Pomalidomide Exporters?

Which Indian Ports Ship Pomalidomide Exports?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Pomalidomide Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pomalidomide Export Data from Hetero Labs Limited

Pomalidomide Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source